Titan Medical Inc (TMD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Titan Medical Inc (TMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7235
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Titan Medical Inc (Titan) is a development stage company that designs and develops a robotic surgical system for application in minimally invasive surgery (MIS). The company’s lead product candidate, single port robotic (SPORT) surgical system is a single-incision robotic surgical system. It includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments. SPORT system provides a 3D endoscopic view of the patient’s internal body during MIS procedures and is designed to perform various general abdominal, gynecologic and urologic procedures. Titan is headquartered in Toronto, Canada.

Titan Medical Inc (TMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Titan Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Titan Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Titan Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Titan Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Titan Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Titan Medical Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Titan Medical to Acquire SPORT Surgical System from Platform Imaging 11
Partnerships 12
Titan Medical Enters into Licensing Agreement with Mayo Clinic 12
Titan Medical Enters Into Licensing Agreement With Columbia University For Insertable Robotic Effector Platform 13
Titan Medical Enters into Collaboration Agreement with Mimic Technologies 14
Titan Medical Partners with Cadence 15
Equity Offering 16
Titan Medical Prices Public Offering of Share for up to USD20 Million 16
Titan Medical Raises USD18 Million in Public Offering of Units 17
Titan Medical Raises USD2.6 Million in Final Tranche of Private Placement of Shares 18
Titan Medical Raises USD6.6 Million in Private Placement of Shares up on Exercise of Warrants 19
Titan Medical Raises USD2 Million in Private Placement of Shares 20
Titan Medical Raises USD1.3 Million in Second Tranche of Public Offering of Units 21
Titan Medical Raises USD5.4 Million in Public Offering of Units 22
Titan Medical Raises USD5.6 Million in Public Offering of Units 23
Titan Medical Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares for USD9 Million 24
Titan Medical to Raise USD16 Million in Private Placement of Shares 26
Titan Medical Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering for USD13.3 Million 27
Titan Medical Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering for USD8.8 Million 28
Titan Medical Raises USD4 Million in Private Placement of Shares 29
Titan Medical Raises USD9 Million in Public Offering of Units 30
Titan Medical Completes Public Offering Of Units For US$23.3 Million 31
Titan Medical Completes Public Offering Of Units For US$11.5 Million 32
Titan Medical Completes Public Offering Of Units For US$6.4 Million 33
Titan Medical Completes Private Placement Of Units For US$3 Million 34
Titan Medical Inc – Key Competitors 35
Titan Medical Inc – Key Employees 36
Titan Medical Inc – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Financial Announcements 38
Aug 13, 2018: Titan Medical reports second quarter 2018 financial results 38
May 14, 2018: Titan Medical announces Q1 2018 financial results 39
Feb 13, 2018: Titan Medical Reports 2017 Financial Results 40
Nov 09, 2017: Titan Medical Reports Third Quarter 2017 Financial Results 41
Aug 08, 2017: Titan Medical Reports Second Quarter 2017 Financial Results 42
May 11, 2017: Titan Medical Reports First Quarter 2017 Financial Results 43
Mar 21, 2017: Titan Medical Reports Financial Results for Fiscal Year Ended December 31, 2016 44
Corporate Communications 45
Aug 02, 2018: Titan Medical expands advisory role for Dr. Arnold Advincula to include clinical education and hospital economics 45
Jun 28, 2018: Titan Medical Names Domenic Serafino As Board Director 46
Mar 15, 2018: Titan Medical Announces Resignation Of Martin Bernholtz As Director And Chairman 47
Apr 03, 2017: Titan Medical Appoints Curtis R. Jensen Vice President of Quality and Regulatory Affairs 48
Feb 06, 2017: Titan Medical Appoints Perry A. Genova Vice President of Research and Development 49
Jan 09, 2017: Titan Medical Announces Senior Management Change 50
Jan 03, 2017: Healthcare Industry Leader David J. McNally Named CEO of Titan Medical 51
Product News 52
Mar 27, 2018: Titan Medical Granted U.S. Patent for Robotic Surgical Instruments 52
Feb 27, 2018: Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery 53
Other Significant Developments 54
Jul 09, 2018: Titan Medical Announces Achievement of all Second Quarter 2018 SPORT Surgical System Development Milestones 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Titan Medical Inc, Medical Equipment, Key Facts, 2017 2
Titan Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Titan Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Titan Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Titan Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Titan Medical Inc, Deals By Market, 2012 to YTD 2018 9
Titan Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Titan Medical to Acquire SPORT Surgical System from Platform Imaging 11
Titan Medical Enters into Licensing Agreement with Mayo Clinic 12
Titan Medical Enters Into Licensing Agreement With Columbia University For Insertable Robotic Effector Platform 13
Titan Medical Enters into Collaboration Agreement with Mimic Technologies 14
Titan Medical Partners with Cadence 15
Titan Medical Prices Public Offering of Share for up to USD20 Million 16
Titan Medical Raises USD18 Million in Public Offering of Units 17
Titan Medical Raises USD2.6 Million in Final Tranche of Private Placement of Shares 18
Titan Medical Raises USD6.6 Million in Private Placement of Shares up on Exercise of Warrants 19
Titan Medical Raises USD2 Million in Private Placement of Shares 20
Titan Medical Raises USD1.3 Million in Second Tranche of Public Offering of Units 21
Titan Medical Raises USD5.4 Million in Public Offering of Units 22
Titan Medical Raises USD5.6 Million in Public Offering of Units 23
Titan Medical Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares for USD9 Million 24
Titan Medical to Raise USD16 Million in Private Placement of Shares 26
Titan Medical Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering for USD13.3 Million 27
Titan Medical Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering for USD8.8 Million 28
Titan Medical Raises USD4 Million in Private Placement of Shares 29
Titan Medical Raises USD9 Million in Public Offering of Units 30
Titan Medical Completes Public Offering Of Units For US$23.3 Million 31
Titan Medical Completes Public Offering Of Units For US$11.5 Million 32
Titan Medical Completes Public Offering Of Units For US$6.4 Million 33
Titan Medical Completes Private Placement Of Units For US$3 Million 34
Titan Medical Inc, Key Competitors 35
Titan Medical Inc, Key Employees 36

List of Figures
Titan Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Titan Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Titan Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Titan Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Titan Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Titan Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Titan Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Titan Medical Inc (TMD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Walvax Biotechnology Co Ltd (300142):製薬・医療:M&Aディール及び事業提携情報
    Summary Walvax Biotechnology Co Ltd (Walvax) is a biopharmaceutical company that develops, produces and markets bio-medical products including vaccines and blood products. The company's products include haemophilus influenzae vaccine for the prevention of infectious diseases such as meningitis. Walv …
  • bluebird bio Inc (BLUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immuno …
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company provides smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It of …
  • University of Chicago-製薬・医療分野:企業M&A・提携分析
    Summary University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master’s and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biolo …
  • Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報
    Summary Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early d …
  • Mitsui O.S.K. Lines, Ltd.:企業の戦略・SWOT・財務分析
    Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務情報
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …
  • UNIQA Ukraine:企業の戦略・SWOT・財務情報
    UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report Summary UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Astrotech Corporation
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Southwestern Electric Power Co:発電所・企業SWOT分析
    Southwestern Electric Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CHC Group Ltd:企業の戦略的SWOT分析
    CHC Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Toromont Industries Ltd:企業の戦略・SWOT・財務情報
    Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Principia Biopharma Inc (PRNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. The company, through its proprietary Tailored Covalency platform, develops a portfolio of drug candidates …
  • Essential Energy:企業の戦略的SWOT分析
    Essential Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) operates as a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents …
  • Lufthansa Cityline Gmbh:企業の戦略・SWOT・財務情報
    Lufthansa Cityline Gmbh - Strategy, SWOT and Corporate Finance Report Summary Lufthansa Cityline Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MedImmune LLC:企業のM&A・事業提携・投資動向
    MedImmune LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MedImmune LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Mitsubishi Tanabe Pharma Corp (4508):製薬・医療:M&Aディール及び事業提携情報
    Summary Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆